1. Introduction {#sec1}
===============

Autoimmune thyroid disease (AITD), known to be the most common endocrine autoimmune disease, is an organic disease caused by immune irregulation related to the thyroid gland. AITD mainly includes two subtypes, Graves\' disease (GD) and Hashimoto\'s thyroiditis (HT). The prevalence of AITD in the whole population has reached 2%--5% \[[@B1]\]. The presence of autoimmune antibodies, including antibody against TSH receptor (TRAb), anti-TPO antibody (TPOAb), and thyroglobulin antibody (TGAb), is the key immunological feature of AITD. AITD is also an immune polygenic disorder with a strong genetic component \[[@B2]\]. Recent advances in understanding the genetic basis for AITD documented the potential involvement of several genes in its pathophysiology. Polymorphisms in the genes, like TNFAIP3 \[[@B2], [@B3]\], IL-37 \[[@B4]\], and IRAK1/MECP2 \[[@B5]\], have been implicated in the occurrence and development of AITD.

Interleukin-22 (IL-22), belonging to the IL-10 cytokine family, is mainly expressed and secreted by Th22 (CD4 + IL22+) cells \[[@B6]\]. IL-22 gene polymorphisms have been found to be a risk factor for various autoimmune diseases, like psoriasis vulgaris \[[@B7]\] and celiac disease \[[@B8]\]. Recently, a study of ours revealed the protein level of interleukin-22 (IL-22) in serum, and the expression of IL-22 mRNA in peripheral blood mononuclear cells (PBMCs) was elevated in GD patients compared to healthy volunteers, implying IL-22 as an inflammatory cytokine participating in GD \[[@B9]\]. However, the relationship between IL-22 polymorphisms and AITD as yet remains unknown.

The present study was focused on investigating the allele frequencies, genotype distributions of the IL-22 variants, and their correlation with the development of AITD and its clinical phenotypes.

2. Material and Methods {#sec2}
=======================

2.1. Ethics Statement {#sec2.1}
---------------------

This study was approved by the institutional review board of Jinshan Hospital of Fudan University. The importance of the research was explained to all participants and written informed consent was obtained from each participant prior to the research.

2.2. Design and Setting {#sec2.2}
-----------------------

A case-control pilot was performed to define the allelic and genotypic profiles of polymorphisms (rs2046068, rs2227478, rs2227485, rs1179251, and rs11611206) within the IL-22 region in autoimmune thyroid disease in a cohort of Chinese origin and subphenotype groups.

2.3. Study Participants {#sec2.3}
-----------------------

In total, all the subjects (including established AITD patients and controls) were local ethnic Han Chinese. The study group enrolled 975 patients first diagnosed with AITD, including 639 Graves\' disease and 336 Hashimoto\'s thyroiditis ones, and 851 healthy volunteers. The inclusion criterion to the AITD was consistent with that as detailed in our previous papers \[[@B5], [@B10]\]. GD diagnosis was based on clinical manifestations, laboratory assessments (hyperthyroidism and positive TRAb, with or without positive TPOAb or TgAb), and diffuse goiter of the thyroid; HT was diagnosed based on the positive of either TPOAb or TgAb, with or without clinical and biochemical hypothyroidism and the presence of an enlarged thyroid. The suspected HT patients were further confirmed by the more accurate fine needle aspiration biopsies. The criterion for diagnosis of euthyroid in HT patients is normal TSH, FT3, and FT4. All AITD patients were collected from the Out-patient Clinic of Endocrinology of Jinshan Hospital of Fudan University. The sex- and age-matched controls were from the Healthy Check-up Center of the same hospital, and they had no sibship with individuals in the patient group. The exclusion criteria for control subjects were positive thyroid antibodies against TPO tested by the immunochemiluminescence method (Roche Company, Shanghai, China) with high specificity and sensitivity. All the clinical and laboratory parameters were collected from patients\' files and then analyzed.

2.4. Genotyping {#sec2.4}
---------------

Genomic DNA from AITD patients and healthy volunteers was extracted from 2 ml of peripheral whole blood using commercial RelaxGene Blood DNA System provided by Tiangen Biotech Company (Beijing, China), in accordance with the manufacturer\'s protocol. All DNA samples measured the concentration and A260/A280 ratio by NanoDrop 2000 Spectrophotometer provided by Thermo Scientific Company (USA). Only the DNA samples with great purity and concentration were prepared for the next polymorphism genotyping.

In the present study, marker-tagging single-nucleotide polymorphisms (SNPs) which mapped the IL-22 gene were chosen from the previous studies \[[@B7], [@B8], [@B11]\]. At the same time, we chose marker-tagging SNPs from the Hapmap CHB data using the software named HaploView to meet the following criteria: minor allele frequency (MAF) \>0.05, Hardy-Weinberg equilibrium (HWE) with *p* \> 0.01, and logarithm of odds (LOD) \>3.0. For the IL-22 gene, we finally determined five loci covering the whole region of the gene to capture all the most common variants. In final, five tagSNPs, rs2046068, rs2227478, rs2227485, rs1179251, and rs11611206 of the IL-22 region, were selected. Genotyping was conducted using the ligase detection reaction (LDR) platform according to the manufacturer\'s instruction. Positive controls (duplication of the same DNA samples) and blank controls (blank samples without DNA) were both used in SNP genotyping to further ensure the reliable detection quality. All genotype results were recorded manually by different persons and inconsistent results were regenotyped by direct sequencing. Only SNPs that passed the 98% quality control threshold were subjected to the next statistical analyses. The SNPs with allele frequencies meeting Hardy-Weinberg equilibrium were included for next analysis. Specific primers of the five loci in the IL-22 gene are displayed as follows: rs2046068: forward primer-AAAAGGCAACTCAGGTTGCG,

reverse primer-CTCCCCTCAACAACTTAGAC; (ii) rs2227478: forward primer-TGAGATGGCACAGACCTAAG,

reverse primer-TCTGGCCACCTTCACAAATG; (iii) rs2227485: forward primer-GTTTTGTCTTAGTAGAGTTC;

reverse primer- TGAGTCCGTGACCAAAATGC; (iv) rs11611206: forward primer-CACCTGTGAATCTCAGTTCC,

reverse primer-TCATGCTAGAGACCTGACAC; (v) rs1179251: forward primer-GGTTGGGATCTTAGCTTGTC;

reverse primer-ACCTGCATTCTAGCCCTATC.

2.5. Clinical Subphenotype Analysis {#sec2.5}
-----------------------------------

Clinical subphenotype characteristic analyses were conducted by the case-only approach, in which basic allelic and genotypic examinations were performed by comparing minor allele and genotype frequency of cases with a specific subphenotype to the whole case group. The clinical subphenotypes include (1) onset age of the disease (≤18 years old versus ≥19 years old); (2) with or without thyroid eye disease, patients with mild or more serious than mild (moderate to severe) orbitopathy were diagnosed as ophthalmopathy according to EUGOGO criteria \[[@B12]\]; (3) with or without hypothyroidism in the HT group.

2.6. Statistical Analysis {#sec2.6}
-------------------------

All of the data were mainly tested with the SPSS Statistics 20.0 software (IBM, Armonk, NY). Linkage disequilibrium (LD) test and haplotype frequency calculation were carried on using the software of HaploView 4.2. Evaluation of Hardy-Weinberg equilibrium (HWE) of the five loci using the chi-square (*χ*^2^) test was done prior to performing an association statistics. And exploration of the association was performed by comparing allele and genotype between AITD subjects and healthy ones using the *χ*^2^ test or Fisher\'s exact analysis. Linkage disequilibrium (LD) analysis was performed for the five loci using the HaploView program. Two-tailed *P* values \<0.05 were considered of statistical significance in all assessments. Odds ratio (OR) was to assess the correlation between each locus and AITD.

3. Results {#sec3}
==========

3.1. Characteristics of Chinese AITD and Control Subjects {#sec3.1}
---------------------------------------------------------

[Table 1](#tab1){ref-type="table"} showed all the phenotype information about our cohort. We studied 975 patients with AITD (639 GD cases and 336 HT cases) and 851 healthy volunteers of Chinese origin. In the AITD group, there were 742 female and 233 male patients, and the average age of the patients was 36.210 ± 14.345 years old. The median age at diagnosis was 33.340 ± 14.160 years old (range 1--77 years). There were 202 subjects with family history in the AITD group with a percentage of 20.72%. Additionally, there were 105 teenagers in this case group with a percentage of 10.77%. The percentages of family history were 30.48% in those with onset age ≤18 years old and 12.41% in those subjects with onset age ≥19 years old. Besides, we unraveled that there were 118 AITD patients with ophthalmopathy (with a percentage of 12.10%), including 112 GD patients. TRAb were positive in all GD patients. In addition, in the HT subgroup, 171 subjects had hypothyroidism (at a rate of 50.89%), 79.53% cases were with positive TPOAb (267 ones), and 52.30% cases were with positive TGAb (176 ones). In the control group, there were 567 female and 284 male patients and the average age was 38.700 ± 8.945 years old. No statistical significance was found in comparing the age and gender in the AITD, GD, and HT groups to the control group (*P* \> 0.05, data not shown).

3.2. Hardy-Weinberg Equilibrium Analysis {#sec3.2}
----------------------------------------

IL-22 SNP genotyping identified the genotypes A/A, A/C, and C/C at rs2046068; T/T, T/C, and C/C at rs2227478; C/C, C/T, and T/T at rs2227485; C/C, C/G, and G/G at rs1179251; and G/G, G/A, and A/A at rs11611206. According to the genotyping results, the distributions of all genotypes at rs2046068, rs2227478, rs2227485, rs1179251, and rs11611206 in the IL-22 gene in the control group met the expectations of Hardy-Weinberg equilibrium (*P* \> 0.01). Besides, we detected linkage disequilibrium (LD) between any two loci in the five ones of IL-22. The *D* values between any two loci among the four SNPs (rs2046068, rs2227478, rs2227485, and rs1179251) were obtained larger than 0.9, which shows that the four loci were in strong linkage disequilibrium.

3.3. Allelic and Genotypic Analysis {#sec3.3}
-----------------------------------

There was no significant association between the IL-22 gene polymorphisms (rs2046068, rs2227478, rs2227485, rs1179251, and rs11611206) and AITD, GD, and HT (*P* values all larger than 0.05), which were shown in [Table 2](#tab2){ref-type="table"}. But the frequency of allele A of rs2046068 (77.83%) in HT patients was lower than that in controls (81.02%), although this association failed to reach significant probabilities (*P* = 0.079). Moreover, as seen in [Table 3](#tab3){ref-type="table"}, locus analysis of the alleles and genotype distribution in female AITD patients and female controls indicated that genotype CC of rs1179251 linked to the susceptibility of AITD (*P* = 0.048). But we found no evidence for an association between the allele and genotype distribution and the risk of AITD in male patients (*P* \> 0.05, shown in [Table 3](#tab3){ref-type="table"}).

Similarly, there were no differences in the allele and genotype distributions in male GD and female GD versus those in corresponding controls (*P* values all larger than 0.05, data not shown). Nevertheless, as displayed in [Table 4](#tab4){ref-type="table"}, compared to that in male controls, allele C at rs2046068, allele C at 2227478, and allele C at 1179251 can increase the risk towards the predisposition of HT in males (*P* = 0.0.27, *P* = 0.031, and *P* = 0.039, resp.). The difference in allele frequency observed for the polymorphism in rs1179251 was further verified by genotype probabilities, and genotype CC of rs1179251 was also associated with HT in male subjects (*P* = 0.007).

3.4. Genotyping-Phenotype Correlations {#sec3.4}
--------------------------------------

When next comparing the allele and genotype distributions of IL-22 polymorphisms the onset age between ≤18 years old and ≥19 years old, we found that genotype A/C at rs2046068, T/C at rs2227478, and C/G at rs1179251 were associated with the onset age in teenagers. Among them, A/C at rs2046068 and T/C at rs2227478 linked to the AITD adolescents (*P* = 0.034 and *P* = 0.028, resp.). Besides, the frequency of allele C at rs1179251 in AITD youngsters was more than that in AITD adults (*P* = 0.039, OR = 1.397). We further analyzed the allele and genotype frequencies of IL-22 SNPs with ophthalmopathy in AITD patients, and this study demonstrated that the SNP rs11611206 within the IL-22 gene was associated with thyroid-associated ophthalmopathy (TAO) (*P* = 0.023). Furthermore, the allele G in rs11611206 can decrease the risk of TAO by 28.9% (*P* = 0.097). The above data were all shown in [Table 5](#tab5){ref-type="table"}.

As shown in [Table 6](#tab6){ref-type="table"}, the similar stratification analysis method was conducted in the subgroup in GD and HT. Similarly, the genotypes CC in rs1179251 and GG in rs11611206 were correlated with Graves\' ophthalmopathy (GO) (*P* = 0.036 and *P* = 0.045, resp.). In hypothyroidism patients with HT versus euthyroidism subjects with HT, the results showed the correlation with G allele in rs11611206 (*P* = 0.024, OR = 1.828).

3.5. Haplotype Analysis {#sec3.5}
-----------------------

[Figure 1](#fig1){ref-type="fig"} showed that haplotype analysis performed for the 5 SNPs revealed that only one block exists including rs2046068, rs2227478, rs2227485, and rs1179251. [Table 7](#tab7){ref-type="table"} displayed that there were three main haplotypes, namely, CATT, GACT, and CCCC, of these four loci. Through HaploView software examination, there was no association between those three haplotypes and AITD, GD, and HT (*P* \> 0.05).

4. Discussion {#sec4}
=============

Recently, it is clear that AITD has become one of the most important autoimmune healthcare in the population. However, the pathogenesis of AITD remains elusive. As we all know, the occurrence of AITD is with obvious sex tendency, and this disease is more popular in women with the ratio of female to male being 5 : 1 to 10 : 1 \[[@B13]\]. The disease also displays a family aggregation phenomenon, as there are 40%--50% of patients with their families suffering from thyroid disease \[[@B14]\]. Increasing data have demonstrated that environment factors, immune elements, and genetic susceptibility are all involved in the etiology of this disease \[[@B15], [@B16]\].

IL-22, as a member of IL-10 cytokine superfamily, is mainly secreted by Th22 cells and also by their dominant functional cytokine \[[@B17]\]. Our precious publication about a functional study to explore the possible biological mechanisms underlying the association between IL-22 and AITD has indicated that serum IL-22, the mRNA expression of IL-22, and Th22 cells are all increased in GD patients, implying that IL-22 as a proinflammatory factor participates in onset and development of AITD \[[@B9]\]. Recent studies have demonstrated associations between several variants of IL-22 and multiple immune-related diseases \[[@B7], [@B8], [@B11], [@B18]\]. In the present study, we attempted to find out the potential link of polymorphisms of IL-22 with the risk of AITD.

There were no significant differences among the five IL-22 gene polymorphism distribution in the whole AITD, GD, and HT subjects and controls, except that there was a weak association between allele A of rs2046068 and HT patients (although with no statistical significance). Because of the gender trend in AITD \[[@B13]\], we subsequently conducted the sex-stratified analysis and indeed found some interesting and significant results through gender-stratified comparison. The results of our case-control study discovered that several loci of IL-22 are associated with the susceptibility of AITD in the Han Chinese population. For instance, genotype GG in rs1179251 linked to the female AITD and allele A in rs2046068 and allele T in rs2227478 decreased the risk to HT by 44.3% and 43.6%, respectively, and allele C in rs1179251 increased the predisposition for HT by 73.9% in male patients. The current study and our precious report \[[@B9]\] both imply that IL-22 participates in the pathogenesis of AITD, through polymorphisms and aberrant expression. There is no doubt that IL-22 as a vital cytokine takes part in the immune dysfunction of AITD, and as a key gene member, it will be added to the list of genes which influences the predisposition for AITD.

Subsequent phenotype analyses further confirmed the association between IL-22 variants and AITD subphenotypes. In teenagers, the onset of AITD is often with much obvious family history \[[@B14]\], which was also identified in our study that showed that the percentage of family history in teenager patients (30.48%) was higher than that in adult patients (12.41%). Our current research showed that genotype AA in rs2046068 and genotype TT in rs2227478 were correlated with the risk towards teenagers to develop AITD. Besides, it showed that allele C of rs1179251 increases the teenagers\' risk for AITD by 39.7%. Similarly, a pervious paper of ours also reported that there is an association between TNFSF4 gene variations and AITD adolescents \[[@B19]\]. So these results strongly suggest that the occurrence of thyroid dysfunction in teenagers can be caused by family history, which means the genetic background. The eye disorder associated with AITD, called thyroid-associated ophthalmopathy, drastically reduces the quality of life in affected patients and even contributes to the disability of patients \[[@B20]\]. Enormous amounts of documents have shown that TAO is a complex disease with multifaceted mechanism including smoking history, thyroid dysfunction, and positive TRAb \[[@B21], [@B22]\]. We showed for the first time that genotype GG in rs11611206 within IL-22 gene is associated with TAO. When it comes to TAO, most people think first of Graves\' orbitopathy (GO), as more than 80% TAO patients also present with Graves\' disease \[[@B23]\]. In our present study, as for GO, the SNPs in IL-22 at both rs1179251 (genotype CC) and rs11611206 (genotype GG) linked to GO. Autoimmune hypothyroidism is largely caused by Hashimoto\'s thyroiditis, in which irregulatory immune responses against to the thyroid tissue happens \[[@B24]\]; therefore, evaluation of thyroid function in HT is of particular importance. Our results suggested that rs11611206 polymorphism of IL-22, including both allele G and genotype GG, may be a genetic risk factor for autoimmune hypothyroidism in HT. Thus polymorphisms in the IL-22 gene confer predisposition to some subclasses of AITD.

This is the first report about the IL-22 gene polymorphisms in AITD. Also, this is the first study on the link between the loci in the IL-22 region and AITD susceptibility in Chinese population. Further case-control researches with larger populations and more races are needed to identify these observations.

5. Conclusion {#sec5}
=============

Current findings indicated that polymorphisms in IL-22 may explain part of the AITD genetic tendency. To be sure, IL-22 is a risk factor for the development of AITD.
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###### 

Clinical characteristics of AITD patients and controls.

  Clinical phenotype      AITD (%)          GD (%)         HT (%)        Control (%)
  ----------------------- ----------------- -------------- ------------- ----------------
  Number                  975               639            336           851
  Gender                                                                 
   Male                   233 (23.90)       190 (29.73)    43 (12.80)    284 (33.37)
   Female                 742 (76.10)       449 (70.27)    293 (87.20)   567 (66.63)
  Average age             36.210 ± 14.345   ---            ---           38.700 ± 8.945
   ≤18 years              105 (10.77)       ---            ---           ---
    With family history   32 (30.48)        ---            ---           ---
   ≥19 years              870 (89.23)       ---            ---           ---
    With family history   108 (12.41)       ---            ---           ---
  Age at diagnosis        33.340 ± 14.160   ---            ---           ---
  Ophthalmopathy (+)      118 (12.10)       112 (17.53)    6 (1.79)      ---
  Family history (+)      202 (20.72)       ---            ---           ---
  Smoking history (+)     291 (29.85)       ---            ---           ---
  TRAb (+)                ---               639 (100.00)   ---           ---
  TPOAb (+)               ---               ---            267 (79.53)   ---
  TGAb (+)                ---               ---            176 (52.30)   ---
  Hypothyroidism          ---               ---            171 (50.89)   ---

AITD: autoimmune thyroid disease; GD: Graves\' disease; HT: Hashimoto\'s thyroiditis.

###### 

Comparison of allele and genotype frequencies of IL-22 SNPs in AITD, GD, and HT patients and controls.

  SNP ID       Groups         *P* value (OR/95% CI)                                                                                          
  ------------ -------------- ----------------------- -------------- ------------- ---------------------------- ---------------------------- ----------------------------
  rs2046068                                                                                                                                   
   AA          559 (65.69)    622 (63.79)             419 (65.57)    203 (60.42)   0.495                        0.67                         0.211
   CC          31 (3.64)      45 (4.62)               29 (4.54)      16 (4.76)                                                               
   AC          261 (30.67)    308 (31.59)             191 (29.89)    117 (34.82)                                                             
   A           1379 (81.02)   1552 (79.59)            1029 (80.52)   523 (77.83)   0.278 (0.913/0.775--1.076)   0.729 (0.968/0.805--1.163)   0.079 (0.822/0.661--1.023)
   C           323 (18.98)    398 (20.41)             249 (19.48)    149 (22.17)                                                             
  rs2227478                                                                                                                                   
   TT          558 (65.57)    622 (63.80)             418 (65.42)    204 (60.72)   0.609                        0.828                        0.271
   CC          32 (3.76)      44 (4.51)               28 (4.38)      16 (4.76)                                                               
   TC          261 (30.67)    309 (31.69)             193 (30.20)    116 (34.52)                                                             
   T           1377 (80.90)   1553 (79.64)            1029 (80.52)   524 (77.98)   0.339 (0.923/0.784--1.087)   0.790 (0.975/0.812--1.172)   0.108 (0.836/0.671--1.040)
   C           325 (19.10)    397 (20.36)             249 (19.48)    148 (22.02)                                                             
  rs2227485                                                                                                                                   
   CC          246 (28.91)    315 (32.31)             200 (31.30)    115 (34.23)   0.219                        0.508                        0.162
   TT          196 (23.03)    227 (23.28)             150 (23.47)    77 (22.92)                                                              
   CT          409 (48.06)    433 (44.41)             289 (45.23)    144 (42.85)                                                             
   C           901 (52.94)    1063 (54.51)            689 (53.91)    374 (55.65)   0.341 (1.065/0.935--1.214)   0.598 (1.040/0.899--1.203)   0.232 (1.116/0.932--1.335)
   T           801 (47.06)    887 (45.49)             589 (46.09)    298 (44.35)                                                             
  rs1179251                                                                                                                                   
   CC          354 (41.60)    427 (43.79)             278 (43.51)    149 (44.35)   0.179                        0.226                        0.432
   GG          85 (9.99)      115 (11.80)             77 (12.05)     38 (11.31)                                                              
   CG          412 (48.41)    433 (44.41)             284 (44.44)    149 (44.34)                                                             
   C           1120 (65.80)   1287 (66.00)            840 (65.73)    447 (66.52)   0.901 (1.009/0.879--1.157)   0.965 (0.997/0.855--1.161)   0.741 (1.032/0.855--1.247)
   G           582 (34.20)    663 (34.00)             438 (34.27)    225 (33.48)                                                             
  rs11611206                                                                                                                                  
   GG          686 (80.61)    782 (80.21)             506 (79.19)    276 (82.14)   0.298                        0.342                        0.273
   AA          4 (0.47)       11 (1.12)               7 (1.09)       4 (1.19)                                                                
   GA          161 (18.92)    182 (18.67)             126 (19.72)    56 (16.67)                                                              
   G           1533 (90.07)   1746 (89.54)            1138 (89.05)   608 (90.48)   0.596 (0.944/0.761--1.170)   0.364 (0.896/0.707--1.135)   0.765 (1.047/0.774--1.417)
   A           169 (9.93)     204 (10.46)             140 (10.95)    64 (9.52)                                                               

SNP: single-nucleotide polymorphism; AITD: autoimmune thyroid disease; GD: Graves\' disease; HT: Hashimoto\'s thyroiditis; NC: normal controls; OR: odds ratio; CI: confidence interval.

###### 

Allele and genotype distribution of IL-22 SNPs in different sex groups of AITD patients.

  Loci         Male          Female                                                                              
  ------------ ------------- ------------- ------- -------------------- -------------- -------------- ---------- --------------------
  rs2046068                                                                                                       
   AA          195 (68.66)   147 (63.09)   0.230                        364 (64.20)    475 (64.02)    0.955      
   CC          7 (2.47)      11 (4.72)                                  24 (4.23)      34 (4.58)                 
   AC          82 (28.87)    75 (32.19)                                 179 (31.57)    233 (31.40)               
   A           472 (83.10)   369 (79.18)   0.108   0.774/0.566--1.058   907 (79.98)    1183 (79.72)   0.867      0.984/0.811--1.193
   C           96 (16.90)    97 (20.82)                                 227 (20.02)    301 (20.28)               
  rs2227478                                                                                                       
   TT          195 (68.66)   148 (63.52)   0.329                        363 (64.02)    474 (63.88)    0.982      
   CC          8 (2.82)      11 (4.72)                                  24 (4.23)      33 (4.45)                 
   TC          81 (28.52)    74 (31.76)                                 180 (31.75)    235 (31.67)               
   T           471 (82.92)   370 (79.40)   0.148   0.794/0.580--1.086   906 (79.89)    1183 (79.88)   0.901      0.989/0.816--1.199
   C           97 (17.08)    96 (20.60)                                 228 (20.11)    301 (20.28)               
  rs2227485                                                                                                       
   CC          76 (26.76)    64 (27.47)    0.880                        170 (29.98)    251 (33.83)    0.171      
   TT          70 (24.65)    53 (22.74)                                 126 (22.22)    174 (23.45)               
   CT          138 (48.59)   116 (49.79)                                271 (47.80)    317 (42.72)               
   C           290 (51.06)   244 (52.36)   0.676   1.054/0.825--1.346   611 (53.88)    819 (55.19)    0.505      1.054/0.903--1.231
   T           278 (48.94)   222 (47.64)                                523 (46.12)    665 (44.81)               
  rs1179251                                                                                                       
   CC          119 (41.90)   104 (44.63)   0.449                        235 (41.45)    323 (43.53)    0.048^∗^   
   GG          31 (10.92)    18 (7.73)                                  54 (9.52)      97 (13.07)                
   CG          134 (47.18)   111 (47.64)                                278 (49.03)    322 (43.40)               
   C           372 (65.49)   319 (68.45)   0.314   1.143/0.881--1.484   748 (65.96)    968 (65.23)    0.696      0.968/0.823--1.139
   G           196 (34.51)   147 (31.55)                                386 (34.04)    516 (34.77)               
  rs11611206                                                                                                      
   GG          232 (81.69)   184 (78.97)   0.602                        454 (80.07)    598 (80.59)    0.387      
   AA          1 (0.35)      2 (0.86)                                   3 (0.53)       9 (1.21)                  
   GA          51 (17.96)    47 (20.17)                                 110 (19.40)    135 (18.20)               
   G           515 (90.67)   415 (89.06)   0.391   0.837/0.558--1.256   1018 (89.77)   1331 (89.69)   0.946      0.991/0.768--1.279
   A           53 (9.33)     51 (10.94)                                 116 (10.23)    153 (10.31)               

^∗^ *P* \< 0.05. SNP: single-nucleotide polymorphism; AITD: autoimmune thyroid disease; NC: normal controls; OR: odds ratio; CI: confidence interval.

###### 

Allele and genotype analysis of IL-22 SNPs in male patients with HT.

  Loci         Male                                  
  ------------ ------------- ------------ ---------- ----------------------
  rs2046068                                           
   AA          195 (68.66)   22 (51.16)   0.084      
   CC          7 (2.47)      2 (4.65)                
   AC          82 (28.87)    19 (44.19)              
   A           472 (83.10)   63 (73.26)   0.027^∗^   0.557 (0.329--0.942)
   C           96 (16.90)    23 (26.74)              
  rs2227478                                           
   TT          195 (68.66)   22 (51.16)   0.086      
   CC          8 (2.82)      2 (4.65)                
   TC          81 (28.52)    19 (44.19)              
   T           471 (82.92)   63 (73.26)   0.031^∗^   0.564 (0.334--0.954)
   C           97 (17.08)    23 (26.74)              
  rs2227485                                           
   CC          76 (26.76)    11 (25.58)   0.984      
   TT          70 (24.65)    11 (25.58)              
   CT          138 (48.59)   21 (48.84)              
   C           290 (51.06)   43 (50.00)   0.855      0.959 (0.609--0.509)
   T           278 (48.94)   43 (50.00)              
  rs1179251                                           
   CC          119 (41.90)   23 (53.49)   0.007^∗^   
   GG          31 (10.92)    0                       
   CG          134 (47.18)   20 (46.51)              
   C           372 (65.49)   66 (76.74)   0.039^∗^   1.739 (1.024--2.952)
   G           196 (34.51)   20 (23.26)              
  rs11611206                                          
   GG          232 (81.69)   33 (76.74)   0.396      
   AA          1 (0.35)      1 (2.33)                
   GA          51 (17.96)    9 (20.93)               
   G           515 (90.67)   75 (87.21)   0.314      0.702 (0.351--1.403)
   A           53 (9.33)     11 (12.79)              

^∗^ *P* \< 0.05. SNP: single-nucleotide polymorphism; HT: Hashimoto\'s thyroiditis; NC: normal controls; OR: odds ratio; CI: confidence interval.

###### 

Allele and genotype frequencies of IL-22 SNPs with onset age and ophthalmopathy in AITD patients.

  SNP          Onset age of AITD patients   Ophthalmopathy                                                                
  ------------ ---------------------------- ---------------- ------------------------------- -------------- ------------- ----------------------------
  rs2046068                                                                                                                
   AA          556 (63.91)                  66 (62.86)       0.034^∗^                        547 (63.83)    75 (63.56)    0.758
   CC          35 (4.02)                    10 (9.52)                                        38 (4.43)      7 (5.93)      
   AC          279 (32.07)                  29 (27.62)                                       272 (31.74)    36 (30.51)    
   A           1391 (79.94)                 161 (76.67)      0.266 (0.824/0.586--1.159)      1366 (79.70)   186 (78.81)   0.752 (0.948/0.679--1.323)
   C           349 (20.06)                  49 (23.33)                                       348 (20.30)    50 (21.19)    
  rs2227478                                                                                                                
   TT          556 (63.91)                  66 (62.86)       0.028^∗^                        547 (63.83)    75 (63.56)    0.719
   CC          34 (3.91)                    10 (9.52)                                        37 (4.32)      7 (5.93)      
   TC          280 (32.18)                  29 (27.62)                                       273 (31.85)    36 (30.51)    
   T           1392 (80.00)                 161 (76.67)      0.257 (0.821/0.584--1.155)      1367 (79.75)   186 (78.81)   0.736 (0.944/0.676--1.318)
   C           348 (20.00)                  49 (23.33)                                       347 (20.25)    50 (21.19)    
  rs2227485                                                                                                                
   CC          287 (32.99)                  28 (26.67)       0.421                           279 (32.56)    36 (30.51)    0.904
   TT          201 (23.10)                  26 (24.76)                                       199 (23.22)    28 (23.73)    
   CT          382 (43.91)                  51 (48.57)                                       379 (44.22)    54 (45.76)    
   C           956 (54.94)                  107 (50.95)      0.273 (0.852/0.640--1.135)      937 (54.67)    126 (53.39)   0.712 (0.950/0.723--1.248)
   T           784 (45.06)                  103 (49.05)                                      777 (45.33)    110 (46.61)   
  rs1179251                                                                                                                
   CC          372 (42.76)                  55 (52.38)       0.120                           368 (42.94)    59 (50.00)    0.116
   GG          107 (12.30)                  8 (7.62)                                         98 (11.44)     17 (14.41)    
   CG          391 (44.94)                  42 (40.00)                                       391 (45.62)    42 (35.59)    
   C           1135 (65.23)                 152 (72.38)      0.039^∗^ (1.397/1.016--1.920)   1127 (65.75)   160 (67.80)   0.534 (1.097/0.820--1.466)
   G           605 (34.77)                  58 (27.62)                                       587 (34.25)    76 (32.20)    
  rs11611206                                                                                                               
   GG          694 (79.77)                  88 (83.81)       0.386                           696 (81.21)    86 (72.88)    0.023^∗^
   AA          11 (1.26)                    0 (0)                                            11 (1.28)      0 (0)         
   GA          165 (18.97)                  17 (16.19)                                       150 (17.51)    32 (27.12)    
   G           1553 (89.25)                 193 (91.90)      0.236 (1.367/0.814--2.296)      1542 (89.96)   204 (86.44)   0.097 (0.711/0.474--1.066)
   A           187 (10.75)                  17 (8.10)                                        172 (10.04)    32 (13.56)    

^∗^ *P* \< 0.05. SNP: single nucleotide polymorphism; AITD: autoimmune thyroid disease; OR: odds ratio; CI: confidence interval.

###### 

Allele and genotype frequencies of IL-22 SNPs with ophthalmopathy in GD patients and hypothyroidism in HT patients.

  SNP loci     Ophthalmopathy in GD   Hypothyroidism in HT                                                            
  ------------ ---------------------- ---------------------- ---------------------------- ------------- ------------- -------------------------------
  rs2046068                                                                                                            
   AA          348 (66.03)            71 (63.39)             0.611                        100 (60.61)   103 (60.23)   0.818
   CC          22 (4.18)              7 (6.25)                                            9 (5.45)      7 (4.09)      
   AC          157 (29.79)            34 (30.36)                                          56 (33.94)    61 (35.68)    
   A           853 (80.93)            176 (78.57)            0.418 (0.864/0.606--1.231)   256 (77.58)   267 (78.07)   0.877 (1.029/0.715--1.481)
   C           201 (19.07)            48 (21.43)                                          74 (22.42)    75 (21.93)    
  rs2227478                                                                                                            
   TT          347 (65.84)            71 (63.39)             0.558                        101 (61.21)   103 (60.23)   0.789
   CC          21 (3.98)              7 (6.25)                                            9 (5.46)      7 (4.09)      
   TC          159 (30.18)            34 (30.36)                                          55 (33.33)    61 (35.68)    
   T           853 (80.93)            176 (78.57)            0.418 (0.864/0.606--1.231)   257 (77.88)   267 (78.07)   0.952 (1.011/0.702--1.457)
   C           201 (19.07)            48 (21.43)                                          73 (22.12)    75 (21.93)    
  rs2227485                                                                                                            
   CC          166 (31.50)            34 (30.36)             0.958                        65 (39.39)    50 (29.24)    0.139
   TT          124 (23.53)            26 (23.21)                                          36 (21.82)    41 (23.98)    
   CT          237 (44.97)            52 (46.43)                                          64 (38.79)    80 (46.78)    
   C           569 (53.98)            120 (53.57)            0.910 (0.984/0.737--1.313)   194 (58.79)   180 (52.63)   0.108 (0.779/0.574--1.057)
   T           485 (46.02)            104 (46.43)                                         136 (41.21)   162 (47.37)   
  rs1179251                                                                                                            
   CC          221 (41.94)            57 (50.89)             0.045^∗^                     69 (41.82)    80 (46.78)    0.173
   GG          60 (11.38)             17 (15.18)                                          24 (14.54)    14 (8.19)     
   CG          246 (46.68)            38 (33.93)                                          72 (43.64)    77 (45.03)    
   C           688 (65.28)            152 (67.86)            0.460 (1.123/0.826--1.528)   210 (63.64)   237 (69.30)   0.120 (1.290/0.936--1.778)
   G           366 (34.72)            72 (32.14)                                          120 (36.36)   105 (30.70)   
  rs11611206                                                                                                           
   GG          425 (80.65)            81 (72.32)             0.036^∗^                     128 (77.57)   148 (86.55)   0.086
   AA          7 (1.33)               0 (0)                                               3 (1.82)      1 (0.58)      
   GA          95 (18.02)             31 (27.68)                                          34 (20.61)    22 (12.87)    
   G           945 (89.66)            193 (86.16)            0.128 (0.718/0.468--1.102)   290 (87.88)   318 (92.98)   0.024^∗^ (1.828/1.075--3.106)
   A           109 (10.34)            31 (13.84)                                          40 (12.12)    24 (7.02)     

^∗^ *P* \< 0.05. SNP: single nucleotide polymorphism; GD: Graves\' disease; HT: Hashimoto\'s thyroiditis; OR: odds ratio; CI: confidence interval.

###### 

Distribution of haplotypes for IL-22 gene polymorphisms in AITD, GD, and HT patients and controls groups.

  Haplotypes   AITD   GD    HT    NC    *P* value for association           
  ------------ ------ ----- ----- ----- --------------------------- ------- -------
  CATT         887    589   298   794   0.429                       0.693   0.294
  GACT         662    438   224   573   0.914                       0.807   0.841
  CCCC         395    247   148   321   0.310                       0.783   0.087

AITD: autoimmune thyroid disease; GD: Graves\' disease; HT: Hashimoto\'s thyroiditis; NC: normal controls.

[^1]: Academic Editor: Michael Horowitz
